Request Your Free Infographic Now:

"Pathways to Licensing: Streamlining Operations to Maximize Oncology Asset Value"

Download this infographic to learn more.

With oncology representing nearly 40% of global pharma licensing deals and over $25 billion in annual payments, timing is critical—especially as licensing windows shrink due to policy changes like the IRA. Sponsors are increasingly focused on earlier-stage assets and expanding clinical plans to global regions.

Access this exclusive content to learn about key strategic approaches for speeding up licensing readiness, including:

• How to use AI to optimize site selection and expand into emerging regions
• Ways to refine endpoint strategies with surrogate and interim analyses
• Tips for pursuing broader indication strategies to increase asset value
• Insights to improve data quality and speed through centralized platforms and predictive analytics
• And more

Don’t miss out! See how implementing the right tactics can compress timelines, command higher upfront payments, and facilitate smoother post-deal transitions.

Offered Free by: Premier Research
See All Resources from: Premier Research